TY - JOUR
T1 - Architecture of the Japan ischemic heart disease multimodal prospective data acquisition for precision treatment (J-IMPACT) system
AU - Matoba, Tetsuya
AU - Kohro, Takahide
AU - Fujita, Hideo
AU - Nakayama, Masaharu
AU - Kiyosue, Arihiro
AU - Miyamoto, Yoshihiro
AU - Nishimura, Kunihiro
AU - Hashimoto, Hideki
AU - Yasuaki, Antoku
AU - Nakashima, Naoki
AU - Ohe, Kazuhiko
AU - Ogawa, Hisao
AU - Tsutsui, Hiroyuki
AU - Nagai, Ryozo
N1 - Funding Information:
This work was funded by ImPACT program of the council for science, technology and innovation (Cabinet Office, Government of Japan). This work was partly supported by the Japan society for the promotion of science through the funding program for world-leading innovative research and development on science and technology (FIRST Program), initiated by the council for science and technology policy (Cabinet Office, Government of Japan). This work was partly supported by a grant from the Ministry of Health, Labor and Welfare (MHLW), the government of Japan, and Japan Agency for Medical Research and Development. This work was supported by the committee of IT/database, the Japanese Circulation Society, Tokyo, Japan.
Publisher Copyright:
© 2019, International Heart Journal Association. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Summary The utilization of electronic medical records and multimodal medical data is an ideal approach to build a real-time and precision registry type study with a smaller effort and cost, which may fill a gap between evidence-based medicine and the real-world clinical practice. The Japan Ischemic heart disease Multimodal Prospective data Acquisition for preCision Treatment (J-IMPACT) project aimed to build an clinical data registry system that electronically collects not only medical records, but also multimodal data, including coronary angiography and percutaneous coronary intervention (PCI) report, in standardized data formats for clinical studies. The J-IMPACT system comprises the standardized structured medical information exchange (SS-MIX), coronary angiography and intervention reporting system (CAIRS), and multi-purpose clinical data repository system (MCDRS) interconnected within the institutional network. In order to prove the concept, we acquired multimodal medical data of 6 consecutive cases that underwent PCI through the J-IMPACT system in a single center. Data items regarding patient background, laboratory data, prescriptions, and PCI/cardiac catheterization report were correctly acquired through the J-IMPACT system, and the accuracy of the multimodal data of the 4 categories was 100% in all 6 cases. The application of J-IMPACT system to clinical studies not only fills the gaps between randomized clinical trials and real-world medicine, but may also provide real-time big data that reinforces precision treatment for each patient.
AB - Summary The utilization of electronic medical records and multimodal medical data is an ideal approach to build a real-time and precision registry type study with a smaller effort and cost, which may fill a gap between evidence-based medicine and the real-world clinical practice. The Japan Ischemic heart disease Multimodal Prospective data Acquisition for preCision Treatment (J-IMPACT) project aimed to build an clinical data registry system that electronically collects not only medical records, but also multimodal data, including coronary angiography and percutaneous coronary intervention (PCI) report, in standardized data formats for clinical studies. The J-IMPACT system comprises the standardized structured medical information exchange (SS-MIX), coronary angiography and intervention reporting system (CAIRS), and multi-purpose clinical data repository system (MCDRS) interconnected within the institutional network. In order to prove the concept, we acquired multimodal medical data of 6 consecutive cases that underwent PCI through the J-IMPACT system in a single center. Data items regarding patient background, laboratory data, prescriptions, and PCI/cardiac catheterization report were correctly acquired through the J-IMPACT system, and the accuracy of the multimodal data of the 4 categories was 100% in all 6 cases. The application of J-IMPACT system to clinical studies not only fills the gaps between randomized clinical trials and real-world medicine, but may also provide real-time big data that reinforces precision treatment for each patient.
UR - http://www.scopus.com/inward/record.url?scp=85063295427&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063295427&partnerID=8YFLogxK
U2 - 10.1536/ihj.18-113
DO - 10.1536/ihj.18-113
M3 - Article
C2 - 30799376
AN - SCOPUS:85063295427
SN - 1349-2365
VL - 60
SP - 264
EP - 270
JO - International Heart Journal
JF - International Heart Journal
IS - 2
ER -